Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
A straightforward framework to help newcomers pick their initial cryptocurrency with confidence.
24,686 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
REZ steadies its footing as a mix of healthcare REITs and self-storage assets cushions exposure to a softening reside...
Gen Z entrepreneurs are using AI tools to launch startups faster. A new industry report highlights AI’s growing role ...
Two affordable small-cap stocks under $15 are drawing retail investors' attention as steady packaged foods demand and...
As AI tools become integral to budgeting and investing, households face a sharp choice: embrace the cyborg shift or r...
Self-employed workers who filed paper returns in the 1990s may have missing earnings data, risking tens of thousands ...
A Fortune interview reveals that Trump’s leadership model succession may not be transferrable, prompting investors an...
A 63-year-old faces a pivotal retirement choice: retire now or stay employed. With $480,000 saved and no pension, two...
A 64-year-old couple skipped a long-term care policy at 58 and now faces six-figure potential costs as health and ins...
Astera Labs’ stock jumped after management laid out a firm timetable for a new switch and signaled growing opportunit...
Mortgage applications fall 2.3% last week as borrowing costs move higher, signaling a cooling in home-purchase activi...
The House passed an amended ROAD to Housing Act, striking the seven-year selloff for new BTR communities while keepin...